logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers who have significant controls over the individuals in focus are always inapplicable. The offspring entities and appointments are those entities that the individuals in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Offsprings
Parent entities and officers
Inapplicable
parent relation
Individuals in focus

Mr Richard Michael Lee

    Related profiles found in government register
  • Mr Richard Michael Lee
    British born in December 1981

    Resident in England

    Registered addresses and corresponding companies
    • C/o The Cambridge Partnership, The Dorothy Hodgkin Building, Babraham Research Campus, Cambridge, CB22 3FH, United Kingdom

      IIF 1
    • The Cambridge Partnership, The Dorothy Hodgkin Building, Babraham Research Campus, Cambridge, CB22 3FH, United Kingdom

      IIF 2 IIF 3 IIF 4
    • The Dorothy Hodgkin Building, Babraham Research Campus, Babraham, Cambridge, CB22 3FH, United Kingdom

      IIF 5
  • Lee, Richard Michael
    British born in December 1981

    Resident in England

    Registered addresses and corresponding companies
    • Cambridge Partnership, Dorothy Hodgkin Building, Babraham Research Campus, Babraham, Cambridge, CB22 3FH, England

      IIF 6
    • C/o The Cambridge Partnership, The Dorothy Hodgkin Building, Babraham Research Campus, Cambridge, CB22 3FH, United Kingdom

      IIF 7
    • The Cambridge Partnership, Dorothy Hodgkin Bldg, Babraham Research Campus, Babraham, Cambridge, CB22 3FH, United Kingdom

      IIF 8
    • The Cambridge Partnership, The Dorothy Hodgkin Bldg, Babraham Research Campus, Cambridge, CB22 3FH, United Kingdom

      IIF 9
    • The Cambridge Partnership, The Dorothy Hodgkin Building, Babraham Research Campus, Cambridge, CB22 3FH, United Kingdom

      IIF 10 IIF 11
    • The Dorothy Hodgkin Building, Babraham Research Campus, Babraham, Cambridge, CB22 3FH, United Kingdom

      IIF 12
    • 2nd Floor Maritime Place, Quayside, Chatham Maritime, Kent, ME4 4QZ

      IIF 13
    • 2nd Floor, 168 Shoreditch High Street, London, E1 6RA, United Kingdom

      IIF 14 IIF 15
    • Innovation House, Innovation Way, Discovery Park, Sandwich, Kent, CT13 9FF, United Kingdom

      IIF 16
  • Lee, Richard Michael
    British company director born in December 1981

    Resident in England

    Registered addresses and corresponding companies
    • C/o The Cambridge Partnership, The Dorothy Hodgkin Building, Babraham Research Campus, Babraham, Cambridge, CB22 3FH, England

      IIF 17
    • Salisbury House, Station Road, Cambridge, CB1 2LA

      IIF 18 IIF 19
  • Lee, Richard Michael
    born in December 1981

    Resident in England

    Registered addresses and corresponding companies
    • 25, Great Pulteney Street, London, W1F 9LT, England

      IIF 20
child relation
Offspring entities and appointments 15
  • 1
    CALSTAR BIO LIMITED
    13079329
    Salisbury House, Station Road, Cambridge
    Dissolved Corporate (4 parents)
    Officer
    2020-12-14 ~ dissolved
    IIF 19 - Director → ME
    Person with significant control
    2020-12-14 ~ 2020-12-21
    IIF 4 - Ownership of shares – 75% or more OE
    IIF 4 - Ownership of voting rights - 75% or more OE
    IIF 4 - Right to appoint or remove directors OE
  • 2
    CASSINI BIO LIMITED
    16906047
    The Cambridge Partnership The Dorothy Hodgkin Bldg, Babraham Research Campus, Cambridge, United Kingdom
    Active Corporate (2 parents)
    Officer
    2025-12-12 ~ 2026-01-19
    IIF 9 - Director → ME
  • 3
    CENTESSA PHARMACEUTICALS (UK) LIMITED - now
    CENTESSA LIMITED
    - 2022-11-22 13040752
    UNITED MEDICINES BIOPHARMA (MIDCO) LIMITED
    - 2021-02-17 13040752
    3rd Floor 1 Ashley Road, Altrincham, Cheshire, United Kingdom
    Active Corporate (12 parents, 8 offsprings)
    Officer
    2020-11-24 ~ 2021-02-19
    IIF 17 - Director → ME
  • 4
    CENTESSA PHARMACEUTICALS PLC - now
    CENTESSA PHARMACEUTICALS LIMITED - 2021-05-14
    UNITED MEDICINES BIOPHARMA LIMITED
    - 2021-02-17 12973576
    3rd Floor 1 Ashley Road, Altrincham, Cheshire, United Kingdom
    Active Corporate (15 parents, 9 offsprings)
    Officer
    2020-10-26 ~ 2021-01-29
    IIF 12 - Director → ME
    Person with significant control
    2020-10-26 ~ 2021-01-29
    IIF 5 - Ownership of voting rights - 75% or more OE
    IIF 5 - Right to appoint or remove directors OE
    IIF 5 - Ownership of shares – 75% or more OE
  • 5
    FIG THERAPEUTICS LIMITED
    15653158
    The Cambridge Partnership, Dorothy Hodgkin Bldg Babraham Research Campus, Babraham, Cambridge, United Kingdom
    Active Corporate (4 parents)
    Officer
    2024-04-16 ~ 2024-05-13
    IIF 8 - Director → ME
  • 6
    GRAEGIS PHARMACEUTICALS LIMITED
    13680871
    C/o The Cambridge Partnership The Dorothy Hodgkin Building, Babraham Research Campus, Cambridge, United Kingdom
    Active Corporate (8 parents)
    Officer
    2021-10-14 ~ 2023-05-10
    IIF 7 - Director → ME
    Person with significant control
    2021-10-14 ~ 2021-12-01
    IIF 1 - Ownership of voting rights - 75% or more OE
    IIF 1 - Right to appoint or remove directors OE
    IIF 1 - Ownership of shares – 75% or more OE
  • 7
    MEDICXI VENTURES (UK) LLP
    OC402437
    25 Great Pulteney Street, London, England
    Active Corporate (9 parents)
    Officer
    2021-01-01 ~ now
    IIF 20 - LLP Designated Member → ME
  • 8
    PELEUS THERAPEUTICS LIMITED
    13076921
    Salisbury House, Station Road, Cambridge
    Dissolved Corporate (4 parents)
    Officer
    2020-12-11 ~ dissolved
    IIF 18 - Director → ME
    Person with significant control
    2020-12-11 ~ 2020-12-21
    IIF 2 - Right to appoint or remove directors OE
    IIF 2 - Ownership of voting rights - 75% or more OE
    IIF 2 - Ownership of shares – 75% or more OE
  • 9
    PETALION THERAPEUTICS LIMITED
    15363420
    Cambridge Partnership, Dorothy Hodgkin Building Babraham Research Campus, Babraham, Cambridge, England
    Active Corporate (5 parents)
    Officer
    2023-12-20 ~ 2024-04-06
    IIF 6 - Director → ME
  • 10
    PODIUM BIO LIMITED
    13537907
    The Cambridge Partnership The Dorothy Hodgkin Building, Babraham Research Campus, Cambridge, United Kingdom
    Active Corporate (4 parents)
    Officer
    2021-07-29 ~ now
    IIF 10 - Director → ME
  • 11
    TACTIX BIO LIMITED - now
    MEDICXI HOLDCO 1 LIMITED
    - 2026-01-26 16891632
    2nd Floor 168 Shoreditch High Street, London, United Kingdom
    Active Corporate (3 parents)
    Officer
    2025-12-04 ~ 2026-01-19
    IIF 14 - Director → ME
  • 12
    TESSERIS THERAPEUTICS LIMITED
    15156026
    2nd Floor Maritime Place, Quayside, Chatham Maritime, Kent
    Dissolved Corporate (2 parents)
    Officer
    2023-09-22 ~ dissolved
    IIF 13 - Director → ME
  • 13
    THEOREM BIOPHARMACEUTICALS LIMITED
    - now 16513869
    ORTHUS PHARMACEUTICALS LIMITED
    - 2025-10-29 16513869
    2nd Floor 168 Shoreditch High Street, London, United Kingdom
    Active Corporate (4 parents)
    Officer
    2025-06-17 ~ 2025-12-16
    IIF 15 - Director → ME
  • 14
    ULTRAHUMAN LIMITED
    09885211
    Montague Place Quayside, Chatham Maritime, Chatham, Kent
    Dissolved Corporate (8 parents)
    Officer
    2023-06-30 ~ dissolved
    IIF 16 - Director → ME
  • 15
    VIMELA THERAPEUTICS LIMITED
    13611487
    The Cambridge Partnership The Dorothy Hodgkin Building, Babraham Research Campus, Cambridge, United Kingdom
    Active Corporate (8 parents)
    Officer
    2021-09-09 ~ 2021-11-30
    IIF 11 - Director → ME
    Person with significant control
    2021-09-09 ~ 2021-11-30
    IIF 3 - Right to appoint or remove directors OE
    IIF 3 - Ownership of voting rights - 75% or more OE
    IIF 3 - Ownership of shares – 75% or more OE

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 March 2026 and licensed under the Open Government Licence v3.0.